Friday, February 13th, 2015Bedaquiline for Patients with NTM Lung Disease?
Friday, January 02th, 2015Toxic tuberculosis drug
Friday, August 22th, 2014120 week results of Bedaquiline phase 2 study
Wednesday, February 26th, 2014Bedaquiline induces the dormancy regulon
Friday, December 20th, 2013Recommendation by the European Medicines Agency
Friday, February 01th, 2013Celebrating the launch of TMC207/R207910
Sunday, January 06th, 2013Bedaquiline approved by FDA
Sunday, June 24th, 2012Diarylquinolines against ATP synthase
Tuesday, December 21th, 2010Next-gen sequencing for clinical microbiology
Wednesday, December 30th, 2009In vitro resistance to TMC207/R207910
Monday, November 09th, 2009Effects of TMC207/R207910 against leprosy bacteria
Friday, October 16th, 2009Little effect of TMC207/R207910 in the Loebel model
Friday, September 11th, 2009How broad is the antimycobacterial activity of TMC207/R207910?
Thursday, August 27th, 2009Increasing the potential of TMC207/R207910
Friday, June 05th, 2009Significant clinical effects of TMC207/R207910 in patients
Thursday, April 02th, 2009ATP synthase selectivity of TMC207/R207910
Wednesday, January 07th, 2009Unprecedented activity of a once-weekly drug combination
Wednesday, December 31th, 2008ATP synthase related toxicity is unlikely
Monday, October 27th, 2008TMC207/R207910 results in five times higher activity in MDR-TB
Thursday, October 09th, 2008Activity in treatment-naive patients
Thursday, August 21th, 2008Dormant bacteria II
Tuesday, July 29th, 2008Dormant bacteria